The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction
Study Details
Study Description
Brief Summary
This study intends to compare postoperative outcomes of a tissue expander placement following a mastectomy with two different operative techniques. This study will be randomized and double blinded comparing the traditional placement of the tissue expander under an inferolateral serratus muscle flap to a new technique which uses an acellular dermal matrix as an inferolateral sling, instead of the muscle flap.
The study we are proposing will evaluate the question of whether there is a difference between the traditional method of serratus flap and the new technique of using an acellular matrix with tissue expander placement. This will be a double blinded randomized study of thirty women in each group comparing outcomes which will include postoperative pain, complications (wound infection, hematoma, capsular contracture, etc), and patient satisfaction with the procedure.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Traditional Method Arm which uses the Serratus Anterior muscle mobilization for lateral coverage of the tissue expander |
Procedure: Serratus anterior to cover lateral aspect of tissue expander
Traditional use of serratus anterior for coverage of lateral aspect of tissue expander
|
Experimental: Dermamatrix Arm Arm which uses Dermamatrix as the lateral expander coverage |
Procedure: Dermamatrix to cover lateral aspect of tissue expander
Dermamatrix used to cover lateral aspect of breast tissue expander after mastectomy
Other Names:
|
Outcome Measures
Primary Outcome Measures
- postoperative pain [perioperative up to 1 year]
Secondary Outcome Measures
- aesthetic outcome [1 year]
- complications (infection, hematoma, capsular contracture) [1 year]
- Patient satisfaction [1 year]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients presenting to Dr. Wendel's clinic who are older than 17 years of age undergoing a mastectomy and wish to have breast reconstruction with a tissue expander or those who have previously undergone a mastectomy and are now seeking reconstruction will be solicited for the study.
Exclusion Criteria:
-
Preoperative radiation therapy
-
Autoimmune disease
-
Fever
-
Uncontrolled diabetes mellitus
-
Inability to comprehend or cooperate with postoperative instructions
-
Local or systemic infection
-
Have any allergies to the excipient ingredients found in the matrix
-
Pregnancy
-
Low vascularity of the surrounding tissue
-
Mechanical trauma
-
Poor nutrition
-
Poor general medical condition
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Vanderbilt University Medical Center | Nashville | Tennessee | United States | 37232-2345 |
Sponsors and Collaborators
- Vanderbilt University Medical Center
Investigators
- Principal Investigator: Jason J. Wendel, M.D., Vanderbilt University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 070415
- 070415